Adipose-derived Stem Cell Conditioned Media as a Novel Approach for Hair Regrowth in Male Androgenetic Alopecia
Adipose-derived Stem Cell Conditioned Media as a Novel Approach for Hair Regrowth in Male Androgenetic Alopecia: A Randomized, Double-blind Clinical Trial
In the register
The register attaches this trial to Minoxidil (topical), currently at “Approved” in the register. The programme's phase is checked by hand; the trial's is declared by its sponsor.
What the registry records
- Status
- Completed
- Declared phase
- Phase 3
- Sponsor
- Dr. dr. Lili Legiawati, SpKK(K)
- Participants (registry)
- 37
- Start
- October 2021
- Primary completion
- December 2021
- Study completion
- December 2021
- Last registry update
- March 2022
- Countries
- Indonesia
Conditions studied: Alopecia, Androgenetic, Hair Loss/Baldness
Interventions: Non-concentrated adipose-derived stem cell conditioned media and 5% Minoxidil, Concentrated adipose-derived stem cell conditioned media and 5% Minoxidil, Placebo and 5% Minoxidil
Other trials of Minoxidil (topical)
Phase 3 Study to Evaluate the Efficacy and Safety of Oral Minoxidil (N1087) in Men With Androgenetic Alopecia.
- NCT07901426Active, not recruiting
Evaluation of the Scalp Skin Care Effects of Premium Revitalizing Elixir and Topical 5% Minoxidil
Comparison of Outcomes Between Topical Minoxidil Versus Oral Minoxidil for the Treatment of Androgenetic Alopecia
Efficacy & Safety of Minoxidil SL Tablets in Men With AGA
- NCT07056933Not yet recruiting
Effect of Minoxidil Solution Iontophoresis on Androgenic Alopecia
Efficacy of Dihydroartemisinin for Treating Female Androgenetic Alopecia
Efficacy and Safety of 5% Minoxidil Foam in Female Androgenetic Alopecia
Clinical Trial to Evaluate CG2001 in Chinese Adult Male Participants With Androgenetic Alopecia
Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia
Effectiveness and Safety of Platelet-rich Plasma and Topical 5% Minoxidil Combination in Male Androgenetic Alopecia
Treatment of Androgenetic Alopecia in Men for 24 Weeks
- NCT02486848Withdrawn
Minoxidil Dose Response Study in Females Identified Through IVD Testing as Non-Responders to 5% Topical Minoxidil
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.